Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2016, Article ID 4507247, 5 pages
http://dx.doi.org/10.1155/2016/4507247
Case Report

ANA Negative Systemic Lupus Erythematosus Leading to CTEPH, TTP-Like Thrombocytopenia, and Skin Ulcers

1Internal Medicine, Sher-I-Kashmir Institute of Medical Sciences, Srinagar 190011, India
2Rheumatology and Internal Medicine, Sher-I-Kashmir Institute of Medical Sciences, Srinagar 190011, India
3Internal Medicine, Mercy Catholic Medical Center, Philadelphia, PA 19026, USA

Received 2 January 2016; Revised 7 February 2016; Accepted 11 February 2016

Academic Editor: Tsai-Ching Hsu

Copyright © 2016 Khalid Hamid Changal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. L. Gurevitz, J. A. Snyder, E. K. Wessel, J. Frey, and B. A. Williamson, “Systemic lupus erythematosus: a review of the disease and treatment options,” Consultant Pharmacist, vol. 28, no. 2, pp. 110–121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Bertsias, R. Cervera, and D. T. Boumpas, “Systemic lupus erythematosus: pathogenesis and clinical features,” in EULAR Textbook of Rheumatic Diseases, J. W. J. Bijlsma and E. Hachulla, Eds., pp. 476–505, BMJ Group, London, UK, 1st edition, 2012. View at Google Scholar
  3. S. E. Howe and D. M. Lynch, “Platelet antibody binding in systemic lupus erythematosus,” Journal of Rheumatology, vol. 14, no. 3, pp. 482–486, 1987. View at Google Scholar · View at Scopus
  4. F. Fabris, A. Casonato, M. L. Randi, G. Luzzatto, and A. Girolami, “Clinical significance of surface and internal pools of platelet-associated immunoglobulins in immune thrombocytopenia,” Scandinavian Journal of Haematology, vol. 37, no. 3, pp. 215–220, 1986. View at Google Scholar · View at Scopus
  5. M. Michel, V. Chanet, A. Dechartres et al., “The spectrum of Evans syndrome in adults: New insight into the disease based on the analysis of 68 cases,” Blood, vol. 114, no. 15, pp. 3167–3172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. C. Mok, K. W. Lee, C. T. K. Ho, C. S. Lau, and R. W. S. Wong, “A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population,” Rheumatology, vol. 39, no. 4, pp. 399–406, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. P. D. Ziakas, S. Giannouli, E. Zintzaras, A. G. Tzioufas, and M. Voulgarelis, “Lupus thrombocytopenia: clinical implications and prognostic significance,” Annals of the Rheumatic Diseases, vol. 64, no. 9, pp. 1366–1369, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. M. Sultan, S. Begum, and D. A. Isenberg, “Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems,” Rheumatology, vol. 42, no. 2, pp. 230–234, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. P. D. Ziakas, J. G. Routsias, S. Giannouli, A. Tasidou, A. G. Tzioufas, and M. Voulgarelis, “Suspects in the tale of lupus-associated thrombocytopenia,” Clinical and Experimental Immunology, vol. 145, no. 1, pp. 71–80, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. D. R. Budman and A. D. Steinberg, “Hematologic aspects of systemic lupus erythematosus. Current concepts,” Annals of Internal Medicine, vol. 86, no. 2, pp. 220–229, 1977. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Abu-Shakra and Y. Shoenfeld, “Azathioprine therapy for patients with systemic lupus erythematosus,” Lupus, vol. 10, no. 3, pp. 152–153, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Griffiths and P. Emery, “The treatment of lupus with cyclosporin A,” Lupus, vol. 10, no. 3, pp. 165–170, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Levy, Y. Sherer, A. Ahmed et al., “A study of 20 SLE patients with intravenous immunoglobulin—clinical and serologic response,” Lupus, vol. 8, no. 9, pp. 705–712, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Rauova, J. Lukac, Y. Levy, J. Rovensky, and Y. Shoenfeld, “High-dose intravenous immunoglobulins for lupus nephritis—a salvage immunomodulation,” Lupus, vol. 10, no. 3, pp. 209–213, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. D. T. Boumpas, S. Barez, J. H. Klippel, and J. E. Balow, “Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus,” Annals of Internal Medicine, vol. 112, no. 9, pp. 674–677, 1990. View at Publisher · View at Google Scholar · View at Scopus
  16. A. L. Hepburn, S. Narat, and J. C. Mason, “The management of peripheral blood cytopenias in systemic lupus erythematosus,” Rheumatology, vol. 49, no. 12, pp. 2243–2254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. N. You, A. Tefferi, and D. M. Nagorney, “Outcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus,” Annals of Surgery, vol. 240, no. 2, pp. 286–292, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Hall, J. L. McCormick Jr., P. R. Greipp, C. J. Michet, and C. H. McKenna, “Splenectomy does not cure the thrombocytopenia of systemic lupus erythematosus,” Annals of Internal Medicine, vol. 102, no. 3, pp. 325–328, 1985. View at Publisher · View at Google Scholar · View at Scopus
  19. W. A. Wilson, A. E. Gharavi, and J. C. Piette, “International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium,” Lupus, vol. 10, no. 7, pp. 457–460, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. M. T. McClain, M. R. Arbuckle, L. D. Heinlen et al., “The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 50, no. 4, pp. 1226–1232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. C. C. Mok, C. S. Lau, and R. W. Wong, “Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus,” Journal of Rheumatology, vol. 28, no. 4, pp. 766–771, 2001. View at Google Scholar · View at Scopus
  22. G.-M. Deng and G. C. Tsokos, “Pathogenesis and targeted treatment of skin injury in SLE,” Nature Reviews Rheumatology, vol. 11, no. 11, pp. 663–669, 2015. View at Publisher · View at Google Scholar
  23. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 9, article 1725, 1997. View at Google Scholar · View at Scopus
  24. L. Uva, D. Miguel, C. Pinheiro, J. P. Freitas, M. Marques Gomes, and P. Filipe, “Cutaneous manifestations of systemic lupus erythematosus,” Autoimmune Diseases, vol. 2012, Article ID 834291, 15 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. S. R. Koller, C. L. Johnston Jr., C. W. Moncure, and M. V. Waller, “Lupus erythematosus cell preparation, antinuclear factor incongruity. A review of diagnostic tests for systemic lupus erythematosus,” American Journal of Clinical Pathology, vol. 66, no. 3, pp. 495–505, 1976. View at Google Scholar · View at Scopus
  26. A. Kavanaugh, R. Tomar, J. Reveille, D. H. Solomon, and H. A. Homburger, “Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists,” Archives of Pathology & Laboratory Medicine, vol. 124, no. 1, pp. 71–81, 2000. View at Google Scholar
  27. L. S. Cross, A. Aslam, and S. A. Misbah, “Antinuclear antibody-negative lupus as a distinct diagnostic entity—does it no longer exist?” Quarterly Journal of Medicine, vol. 97, no. 5, pp. 303–308, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. V. V. McLaughlin, S. L. Archer, D. B. Badesch et al., “ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation task force on expert consensus documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association,” Journal of the American College of Cardiology, vol. 53, no. 17, pp. 1573–1619, 2009. View at Publisher · View at Google Scholar
  29. V. V. McLaughlin, S. L. Archer, D. B. Badesch et al., “ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association,” Circulation, vol. 119, no. 16, pp. 2250–2294, 2009. View at Publisher · View at Google Scholar
  30. A. Dhala, “Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction,” Clinical and Developmental Immunology, vol. 2012, Article ID 854941, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. I. M. Lang and M. Madani, “Update on chronic thromboembolic pulmonary hypertension,” Circulation, vol. 130, no. 6, pp. 508–518, 2014. View at Publisher · View at Google Scholar · View at Scopus